There is an expanding field of research investigating the benefits of medicines with multiple mechanisms of action across neurological disorders. N‐acetylcysteine (NAC), widely known as an antidote to acetaminophen overdose, is now emerging as treatment of vascular and nonvascular neurological disorders. NAC as a precursor to the antioxidant glutathione modulates glutamatergic, neurotrophic, and inflammatory pathways.

NAC shows potential as a treatment for vascular and nonvascular neurological disorders by modulating glutamatergic, neurotrophic, and inflammatory pathways.

Paper

N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities

References

Citations